This research, likely part of the dataset, analyzed tumor sequencing to identify the amplification of genes such as MDM2 and CDK4 in 12q14-15. It connects these molecular findings to survival and metastasis rates in patients, noting that MDM2 amplification is a key marker distinguishing DDLPS from benign tumors.
Analysis of DNA methylation patterns affecting chemo-resistance in sarcoma patients.
Immune checkpoint inhibitors in sarcomas: a systematic review 13569.rar
Studies on how combinations of drugs (like TKIs and anti-CTLA-4) treat sarcoma, particularly Alveolar Soft Part Sarcoma.
Other related research topics often found in similar databases include: This research, likely part of the dataset, analyzed
Genomic alterations and clinical outcomes in patients with dedifferentiated liposarcoma
If you can specify whether you are looking for or genetic sequencing data from this file, I can provide more precise information. However, they indicate this number is likely part
The provided search results do not contain an article named "13569.rar" directly. However, they indicate this number is likely part of an identifier for research regarding , specifically Dedifferentiated Liposarcoma (DDLPS) , a common form of soft tissue tumor.
